ABBV
AbbVie Inc.
Company Overview
| Mkt Cap | $405.55B | Price | $218.04 |
| Volume | 10.83M | Change | -4.45% |
| P/E Ratio | 94.8 | Open | $223.00 |
| Revenue | $56.3B | Prev Close | $228.20 |
| Net Income | $4.3B | 52W Range | $163.81 - $244.81 |
| Div Yield | 6.56% | Target | $241.32 |
| Overall | 70 | Value | 60 |
| Quality | -- | Technical | 81 |
No chart data available
Stock Overview
Updated DailyAbbVie Inc. (ABBV) is a leading Healthcare company in the Drug Manufacturers - Major industry, currently trading at $218.04 with a market capitalization of $405.55 billion. The stock is positioned in the upper portion of its trading range, demonstrating unrated quality characteristics with a MarketXLS quality score of N/A.
Today's trading session shows ABBV with a volume of 10.83 million shares. The stock opened down 2.28% from yesterday's close of $228.20. Current analyst estimates project earnings of $10.58 per share for this year, with next year targeting $14.41.
ABBV demonstrates very strong technical momentum based on technical analysis. The company trades on the NYE exchange and operates alongside industry peers including PFE, BMY, LLY, AMGN, GILD.
Key investment considerations for ABBV include strong overall investment metrics. The company offers a dividend yield of 6.56% and analyst price targets suggest potential upside of 10.7%. The stock shows fair valuation metrics based on valuation analysis.
Analysis generated on November 2, 2025 at 07:00 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ABBV | $218.04 | -4.5% | 10.83M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |